Targeting Neoantigens for Personalised Immunotherapy.

Area of Science:

• Oncology
• Immunology
• Genomics

Background:

• Immunotherapy is a rapidly evolving field in cancer research.
• Successful cancer treatment increasingly relies on the immune system's response to neoantigens.
• Neoantigens are cancer-specific antigens arising from somatic mutations altering protein sequences.

Purpose of the Study:

• To review the types of cancer antigens recognized by the immune system.
• To discuss methods for exploiting neoantigens in clinical settings for tumor cell targeting.
• To explore the potential of neoantigen-specific targeting for novel cancer therapies.

Main Methods:

• Review of recent studies in immunotherapy and cancer antigen recognition.
• Analysis of massively parallel sequencing techniques for identifying genomic mutations.
• Utilizing algorithms to predict neoantigen processing, presentation, and binding to MHC molecules.

Main Results:

• The immunogenicity of neoantigens suggests only a minority of mutations form targetable epitopes.
• Cancers with a higher frequency of protein-altering somatic variants may offer greater potential for immunotherapy.
• Neoantigens are evident contributors to the success of current immunotherapeutic interventions.

Conclusions:

• Targeting neoantigens holds significant scope for developing new cancer treatment approaches.
• Understanding neoantigen immunogenicity is crucial for effective immunotherapy.
• Personalized cancer vaccines and therapies can be developed based on neoantigen profiles.